Munafa Stock Market Course + Intraday & FNO calls 
Arrowhead Pharmaceuticals (ARWR) Technical (Analysis) Reports Arrowhead Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Arrowhead Pharmaceuticals (ARWR)
Technical Analysis Report for USA stock ARWR Arrowhead Pharmaceuticals. Dated: 10 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ARWR Arrowhead Pharmaceuticals then click here. or read Experts views on Arrowhead Pharmaceuticals or Forecast & share price targets of Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals Opened at 84.00 and Closed at: 76.41, which is -9.99% of previous session's close. It moved within a range of 76.18 and 85.00
The session was a Bearish session with an average volume of 1978181, which is 51.31% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 71.89 and resistance for tomorrow is 80.71
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 73.39, 70.38 resistance for tomorrow's hourly charts is 82.21, 88.02
10 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 82.51 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 80.58 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 77.71 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 70.64 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Arrowhead Pharmaceuticals is 61.95 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Arrowhead Pharmaceuticals is at 80.58 and 200 DMA is at 61.95, while 50 DMA and 100 DMA are at 77.71 and 70.64 respectively
Arrowhead Pharmaceuticals (ARWR) moving average of 20 SMA is at 80.58 and 20 EMA is at 80.72
| Date | Closing Price | 20 SMA | 20 EMA |
| 10 Fri Jul | 76.41 | 80.58 | 80.72 |
| 09 Thu Jul | 84.04 | 80.3 | 81.17 |
| 08 Wed Jul | 85.74 | 79.76 | 80.87 |
| 07 Tue Jul | 86.97 | 79.17 | 80.36 |
| 06 Mon Jul | 86.58 | 78.47 | 79.66 |
| 02 Thu Jul | 83.99 | 77.9 | 78.93 |
Arrowhead Pharmaceuticals (ARWR) moving average of 50 SMA is at 77.71 and 50 EMA is at 77.15
| Date | Closing Price | 50 SMA | 50 EMA |
| 10 Fri Jul | 76.41 | 77.71 | 77.15 |
| 09 Thu Jul | 84.04 | 77.59 | 77.18 |
| 08 Wed Jul | 85.74 | 77.31 | 76.9 |
| 07 Tue Jul | 86.97 | 77.07 | 76.54 |
| 06 Mon Jul | 86.58 | 76.81 | 76.11 |
| 02 Thu Jul | 83.99 | 76.56 | 75.68 |
Arrowhead Pharmaceuticals (ARWR) moving average of 100 SMA is at 70.64 and 100 EMA is at 71.91
| Date | Closing Price | 100 SMA | 100 EMA |
| 10 Fri Jul | 76.41 | 70.64 | 71.91 |
| 09 Thu Jul | 84.04 | 70.51 | 71.82 |
| 08 Wed Jul | 85.74 | 70.3 | 71.57 |
| 07 Tue Jul | 86.97 | 70.06 | 71.28 |
| 06 Mon Jul | 86.58 | 69.81 | 70.96 |
| 02 Thu Jul | 83.99 | 69.58 | 70.64 |
Arrowhead Pharmaceuticals (ARWR) moving average of 200 SMA is at 61.95 and 200 EMA is at 61.69
| Date | Closing Price | 200 SMA | 200 EMA |
| 10 Fri Jul | 76.41 | 61.95 | 61.69 |
| 09 Thu Jul | 84.04 | 61.73 | 61.54 |
| 08 Wed Jul | 85.74 | 61.46 | 61.31 |
| 07 Tue Jul | 86.97 | 61.19 | 61.06 |
| 06 Mon Jul | 86.58 | 60.9 | 60.8 |
| 02 Thu Jul | 83.99 | 60.61 | 60.54 |
Arrowhead Pharmaceuticals has performed better than Pfizer Inc in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Humana Inc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Humana Inc, about 3.75% more returns!
Arrowhead Pharmaceuticals has performed better than Globus Medical in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Concord Medical has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Concord Medical, about 8.54% more returns!
Cardinal Health has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Cardinal Health, about 3.88% more returns!
Arrowhead Pharmaceuticals has performed better than Vistagen Therapeutics in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Si Bone has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Si Bone, about 13.23% more returns!
Ultragenyx Pharmaceutical has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Ultragenyx Pharmaceutical, about 38.3% more returns!
Lipocine Inc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Lipocine Inc, about 7.31% more returns!
Ligand Pharmaceuticals has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Ligand Pharmaceuticals, about 21.54% more returns!
Inovio Pharmaceuticals has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Inovio Pharmaceuticals, about 4.52% more returns!
Immutep has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Immutep, about 10.82% more returns!
Halozyme Therapeutics has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Halozyme Therapeutics, about 5.03% more returns!
Geron Corporation has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Geron Corporation, about 28.89% more returns!
Arrowhead Pharmaceuticals has performed better than Eyegate Pharmaceuticals in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Atossa Genetics in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Angiodynamics Inc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Angiodynamics Inc, about 3.19% more returns!
Altimmune Inc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Altimmune Inc, about 14.68% more returns!
Aceto Corporation has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Aceto Corporation, about 16.12% more returns!
Arrowhead Pharmaceuticals Technical analysis of indicators
Price action analysis of Arrowhead Pharmaceuticals (ARWR) based on a short term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Arrowhead Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Arrowhead Pharmaceuticals in short term but the sell signal is initial and weak.
Arrowhead Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Arrowhead Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Arrowhead Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 80.42 and Arrowhead Pharmaceuticals ARWR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arrowhead Pharmaceuticals ARWR stock. Volume based technical analysis of Arrowhead Pharmaceuticals ARWR stock is negative.
Arrowhead Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ARWR Arrowhead Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ARWR Experts View which covers a lot of information including buying and selling signals
ARWR future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Arrowhead Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Arrowhead Pharmaceuticals (ARWR) Technical (Analysis) Reports Arrowhead Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
